Restarting Sotalol After Time Off

Mandatory In-Hospital Monitoring Requirements

The American College of Cardiology recommends that patients who are reinitiating or restarting sotalol after a period of discontinuation must be treated as new initiations and require hospital admission with continuous ECG monitoring for a minimum of 3 days 1
All patients restarting sotalol require inpatient telemetry monitoring, regardless of their previous tolerance of the medication 1
QT interval monitoring must occur 2-4 hours after each dose during the initiation/reinitiation period 1
If QTc prolongs to ≥500 ms (or ≥550 ms in patients with ventricular conduction abnormalities), the dose must be reduced or discontinued 1

Baseline uncorrected QT interval must be <450 ms 2
Serum electrolytes must be normal (particularly potassium and magnesium) 2
Creatinine clearance must be assessed - sotalol is contraindicated if CrCl <20 mL/min 1
Rule out decompensated heart failure, cardiogenic shock, and severe bradycardia 1
Exclude patients with sinus or AV nodal dysfunction unless a pacemaker is present 1

Starting dose should be 40-80 mg every 12 hours 1
Maximum maintenance dose is 160 mg every 12 hours 1
Renal function: If CrCl 40-60 mL/min, start with 250 mcg every 12 hours; if CrCl 20-40 mL/min, start with 125 mcg every 12 hours 1

Absolute contraindications that preclude restarting sotalol: Prolonged baseline QT interval 1
Severe renal dysfunction (CrCl <20 mL/min) 1
Sinus or AV nodal dysfunction without pacemaker 1
Decompensated systolic heart failure or cardiogenic shock 1
History of torsades de pointes 1
Reactive airway disease/asthma 1

Avoid concomitant QT-prolonging drugs during the restart period 1
Do not use sotalol with other drugs that have SA/AV nodal-blocking properties without careful dose adjustment 1

Measure QTc interval 2-4 hours after each dose 1
Continuous telemetry monitoring 1
If QTc increases by >15% from baseline OR exceeds 500 ms (550 ms with bundle branch block), reduce dose by 50% 1
Safety is greatest when sotalol is started while patient is in sinus rhythm 2

The European Society of Cardiology recommends restarting sotalol in a hospital setting with ECG surveillance due to the risk of QT prolongation and torsades de pointes, especially during re-initiation 3
Sotalol therapy should be initiated only in a monitored setting with daily measurement of the QT interval from a 12-lead ECG, as recommended by the American College of Chest Physicians 4
The drug should be used cautiously in patients with renal insufficiency, as impaired renal function can lead to drug accumulation and increased risk of adverse effects, according to the European Heart Journal 3

The European Society of Cardiology guidelines still emphasize monitored settings for initiation of sotalol therapy 3
The American College of Cardiology recommends hospital-based initiation with continuous ECG monitoring as the standard approach for restarting sotalol 5

Bradycardia and hypotension are common side effects that may require discontinuation of sotalol, as reported in the journal Chest 4
Severe AV conduction disturbances, such as sick sinus syndrome, are absolute contraindications for sotalol therapy, unless a pacemaker is present, according to the European Heart Journal 3

The European Society of Cardiology recommends that sotalol should not be used in patients with left ventricular dysfunction after myocardial infarction, unless an ICD has been implanted 3
Acute phase of myocardial infarction with bradycardia, hypotension, or left ventricular failure is an absolute contraindication for sotalol therapy, as stated in the European Heart Journal 3

Regular monitoring of lung, liver, and thyroid function is needed during long-term sotalol therapy, as recommended by the European Heart Journal 3
The risk of adverse effects increases with longer therapy duration and higher doses of sotalol, according to the European Heart Journal 3